OKYO OKYO Pharma Ltd
Nasdaq · SEC CIK 1849296 · EDGAR
- Bought, last 12 months
- $136.0K 7 purchases by 6 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 26 since 2022-05-18, latest 2026-08-07 16:15
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| CERRONE GABRIELE M | Dir, 10% | $67.6K | — |
| Mantelli Flavio | Chief MEDICAL Off | $28.0K | — |
| Dempsey Robert John | CEO, Dir | $23.1K | — |
| BRANCACCIO JOHN P | Dir | $7,385 | — |
| Patil Rajkumar V. | CSO | $5,011 | — |
| JACOB GARY S | Chief DEVELOPMENT Off, Dir | $4,900 | — |
Transactions 22
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-08-07 16:15 | 2026-07-21 | OKYO | BRANCACCIO JOHN P | Dir | P - Purchase | $1.48 | +5,000 | 35.2K | +17% | +$7,385 |
| A | 2026-08-07 16:15 | 2026-07-22 | OKYO | Dempsey Robert John | CEO, Dir | P - Purchase | $1.54 | +15.0K | 15.0K | New | +$23.1K |
| A | 2026-08-07 16:15 | 2026-07-21 | OKYO | JACOB GARY S | Chief DEVELOPMENT Off, Dir | P - Purchase | $1.40 | +3,500 | 112.4K | +3% | +$4,900 |
| AI | 2026-08-07 16:15 | 2026-07-21 | OKYO | CERRONE GABRIELE M | Dir, 10% | P - Purchase | $1.45 | +22.5K | 10.87M | +0.2% | +$32.6K |
| AI | 2026-08-07 16:15 | 2026-07-20 | OKYO | CERRONE GABRIELE M | Dir, 10% | P - Purchase | $1.40 | +25.0K | 10.85M | +0.2% | +$35.0K |
| A | 2026-08-07 16:15 | 2026-07-21 | OKYO | Mantelli Flavio | Chief MEDICAL Off | P - Purchase | $1.40 | +20.0K | 20.0K | New | +$28.0K |
| A | 2026-08-07 16:15 | 2026-07-27 | OKYO | Patil Rajkumar V. | CSO | P - Purchase | $1.49 | +3,363 | 20.0K | +20% | +$5,011 |
| 2026-07-29 16:45 | 2026-07-27 | OKYO | Patil Rajkumar V. | CSO | A - Grant | $1.49 | +3,363 | 20.0K | +20% | +$5,011 | |
| 2026-07-23 16:20 | 2026-07-22 | OKYO | Dempsey Robert John | CEO, Dir | A - Grant | $1.54 | +15.0K | 15.0K | New | +$23.1K | |
| I | 2026-07-23 16:15 | 2026-07-21 | OKYO | CERRONE GABRIELE M | Dir, 10% | A - Grant | $1.45 | +22.5K | 10.87M | +0.2% | +$32.6K |
| 2026-07-23 16:15 | 2026-07-21 | OKYO | JACOB GARY S | Chief DEVELOPMENT Off, Dir | A - Grant | $1.40 | +3,500 | 112.4K | +3% | +$4,900 | |
| 2026-07-23 16:15 | 2026-07-21 | OKYO | BRANCACCIO JOHN P | Dir | A - Grant | $1.48 | +5,000 | 35.2K | +17% | +$7,385 | |
| 2026-07-22 16:15 | 2026-07-21 | OKYO | Mantelli Flavio | Chief MEDICAL Off | A - Grant | $1.40 | +20.0K | 20.0K | New | +$28.0K | |
| I | 2026-07-21 16:15 | 2026-07-20 | OKYO | CERRONE GABRIELE M | Dir, 10% | A - Grant | $1.40 | +25.0K | 10.85M | +0.2% | +$35.0K |
| I | 2026-06-10 16:30 | 2026-06-08 | OKYO | CERRONE GABRIELE M | Dir, 10% | A - Grant | $1.72 | +300.0K | 10.83M | +3% | +$516.0K |
| MI | 2023-10-31 | 2023-10-23+ | OKYO | CERRONE GABRIELE M | Executive COB, Dir | J - Other | $1.50 | +569.5K | 9.11M | +7% | +$854.3K |
| 2023-09-28 | 2023-09-15 | OKYO | BRANCACCIO JOHN P | Dir | P - Purchase | $1.50 | +16.7K | 16.7K | New | +$25.0K | |
| I | 2022-05-20 | 2022-05-19 | OKYO | CERRONE GABRIELE M | Executive COB, Dir | P - Purchase | $0.08 | +5.80M | 548.98M | +1% | +$464.0K |
| 2022-05-19 | 2022-05-19 | OKYO | JACOB GARY S | CEO, Dir | P - Purchase | $4.00 | +12.5K | 12.5K | New | +$50.0K | |
| I | 2022-05-19 | 2022-05-19 | OKYO | CERRONE GABRIELE M | Non-Executive COB, Dir, 10% | P - Purchase | $4.00 | +37.5K | 62.5K | +150% | +$150.0K |
| AI | 2022-05-18 | 2022-05-17 | OKYO | CERRONE GABRIELE M | Non-Executive COB, Dir, 10% | P - Purchase | $3.87 | +25.0K | 25.0K | New | +$96.8K |
| I | 2022-05-18 | 2022-05-17 | OKYO | CERRONE GABRIELE M | Non-Executive COB, Dir, 10% | P - Purchase | $0.06 | +1.62M | 544.81M | +0.3% | +$97.5K |
Purchase Sale Sale after option exercise All abbreviations